Co-Founder and CEO
Jim Boushell co-founded ProMedDx in 1998 to address the growing need for highly annotated, regulatory-compliant human biospecimens by the life science research communities. He has been responsible for the company’s growth and performance since its inception and actively oversees the corporate direction and many of the new strategic partnerships. Jim has led the development and expansion of ProMedDx services successfully into the clinical study support and biostorage business segments.
Prior to ProMedDx, Jim held director-level roles and managed the expansion and delivery of services for organizations in the biotechnology industry and served as an account executive with Abbott Laboratories Diagnostics Division. Jim holds a Bachelor of Science in business administration from St. Anselm College.